Company Will Exhibit Cannabidiol (CBD) Products at State’s Medical Cannabis Conference in Ann Arbor From August 23-25, 2013
SAN DIEGO, Aug. 19, 2013 (GLOBE NEWSWIRE) — Medical Marijuana Inc. (OTC Pink: MJNA) is pleased to inform shareholders and the general public that HempMedsPX – he master distributor and contracted marketing company for the Medical Marijuana, Inc. corporate portfolio – will be attending and exhibiting at the Michigan Medical Marijuana Conference August 23-25 in Ann Arbor, Michigan.
“This conference will introduce HempMedsPX to the Michigan medical cannabis market,” said Charles Vest, Director of Communications for HempMedsPX. “We will have the opportunity to showcase all current hemp-based products under the HempMedsPX umbrella and establish distribution networks throughout the state.
“We are especially hopeful that we can fill in the gap left by the recent Michigan Court of Appeals ruling that prohibits resin-based edible cannabis from being covered by their medical marijuana legislation. Since our hemp-based CBD products are legal to consume in all fifty states, we are confident that we will be able to assist those medical cannabis patients in Michigan who prefer cannabis oils and edible products.”
In addition to national cannabis-related vendors, the Michigan Medical Marijuana Conference will have doctors on site to assist those looking to join the state’s medical marijuana program. For more information on the conference, visit http://www.mmmrmag.com/index.html.
According to the US government, every product derived from cannabis is categorized as marijuana – including hemp. We, therefore, use the word “marijuana” as an all-encompassing term to cover cannabis, medical marijuana, marijuana and hemp. We believe that “cannabis” should be the standard term used for all medical products; as the industry matures, we will be phasing out the words “medical marijuana” and “marijuana” from the company’s vocabulary.
HempMedsPX is the master distributor and contracted marketing company for the CannaVest Corp. (OTC: CANV) and Medical Marijuana, Inc. (OTC Pink: MJNA) portfolio of products, including their revolutionary hemp-based CBD products. HempMedsPX offers mainstream marketing, sales, customer service, and logistics for the cannabis industry. In addition to handling sales and distribution, HempMedsPX is the communication hub for the Medical Marijuana Inc. portfolio of companies.
About Medical Marijuana, Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally friendly, economically sustainable businesses, while increasing shareholder value. For more information, please visit the company’s website at: www.MedicalMarijuanaInc.com.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. and CannaVest Corp. to be materially different from the statements made herein.
Medical Marijuana, Inc., CannaVest Corp., and HempMedsPX do not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell and distribute hemp-based products and are involved with Federally Legal Distribution of Medical Marijuana based products within certain international markets.
For further information, please contact:
Investor relations contact:
Stuart T. Smith